Evidence map›Paper›PMID 36823619›Full record

ArticleBMC psychiatry2023

Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs.

Yuan Cai, Zhen Hua Zhu, Rong Hua Li, Xu Yuan Yin, Ru Feng Chen, Li Juan Man, Wen Long Hou, Hong Liang Zhu, Jing Wang, Huiping Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yuan Cai *School of Mental Health, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, People's Republic of China.
Zhen Hua Zhu *Research Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Rong Hua Li *Research Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Xu Yuan YinResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Ru Feng ChenResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Li Juan ManResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Wen Long HouResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Hong Liang ZhuResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Jing WangResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China.
Huiping ZhangDepartments of Psychiatry and Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, 02118-2526, USA.
Qiu Fang JiaResearch Center of Biological Psychiatry, Suzhou Guangji Hospital, Medical College of Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China. gjiaqf@163.com.
Li HuiSchool of Mental Health, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, People's Republic of China. huili004100@126.com.
Soochow University · CNSuzhou Guangji Hospital · CNBoston University · USWenzhou Medical University · CN

Funding

CAS Key Laboratory of Mental Health, Institute of Psychology KLMH2019K03Jiangsu Provincial Health Commission Science Research Program H2019056 and LGY2018010Jiangsu Provincial Key Research and Development Program BE2020661Jiangsu Provincial Six Talent Peaks Project WSN-165National Natural Science Foundation of China 81771439Suzhou Municipal Health Commission Science Research Program GSWS2020095Suzhou Municipal Health Commission Science Research Program LCZX202218Suzhou Municipal Sci-Tech Bureau Program SKY2022013Suzhou Municipal Sci-Tech Bureau Program SKY2022064Suzhou Municipal Sci-Tech Bureau Program SKY2022065the Natural Science Foundation of Jiangsu Province BK20200210
6 · The paper itself

Abstract

backgroundThe effect of neuroinflammatory cytokines on cognitive deficits in patients with major depressive disorder (MDD) can be altered by selective serotonin reuptake inhibitors (SSRIs). This study aimed to examine serum interleukin-8 (IL-8) levels, cognitive function, and their associations in MDD patients with SSRIs.

methodsThirty SSRI-treated MDD patients and 101 healthy controls were recruited for this study. We examined cognitive performance using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and serum IL-8 levels using the Human Inflammatory Cytokine Cytometric Bead Array in both cases and controls.

resultsThe RBANS test scores were significantly lower in MDD patients with SSRIs than in healthy controls after controlling for covariates (all p < 0.001). Serum levels of IL-8 were higher in MDD patients with SSRIs than in healthy controls after adjusting for covariates (F = 3.82, p = 0.05). Serum IL-8 levels were positively correlated with sub-scores of delayed memory (r = 0.37, p = 0.04) and visuospatial/constructional (r = 0.43, p = 0.02) in MDD patients with SSRIs but not in in healthy controls (delayed memory score: r = -0.12, p = 0.24; visuospatial/constructional score: r = 0.02, p = 0.81).

conclusionsOur findings suggested that increased serum IL-8 level might not only be involved in the MDD psychopathology or the use of SSRIs but also correspond to improving MDD delayed memory and visuospatial/constructional function.

Indexed as

Cognitive DysfunctionMajor Depressive DisorderCognitionCytokinesHumansInterleukin-8Selective Serotonin Reuptake InhibitorsCytokinesInterleukin-8Selective Serotonin Reuptake InhibitorsCognitive functionInterleukin-8Major depressive disorderSSRIs

Identifiers

PMID36823619
PMCPMC9948487
OpenAlexW4321597292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.